

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 4.08286224 |
| 2 | low-density lipoprotein particle clearance (GO:0034383) | 3.81808613 |
| 3 | regulation of protein activation cascade (GO:2000257) | 3.65627280 |
| 4 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.60810775 |
| 5 | fatty acid elongation (GO:0030497) | 3.60551252 |
| 6 | regulation of complement activation (GO:0030449) | 3.58298296 |
| 7 | regulation of fibrinolysis (GO:0051917) | 3.54344263 |
| 8 | cellular response to ethanol (GO:0071361) | 3.46816270 |
| 9 | oligosaccharide catabolic process (GO:0009313) | 3.45758175 |
| 10 | ribosomal small subunit biogenesis (GO:0042274) | 3.44348866 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 3.42432970 |
| 12 | complement activation, alternative pathway (GO:0006957) | 3.40688871 |
| 13 | proteasome assembly (GO:0043248) | 3.37331636 |
| 14 | detection of molecule of bacterial origin (GO:0032490) | 3.35813174 |
| 15 | negative regulation of protein activation cascade (GO:2000258) | 3.33445868 |
| 16 | positive regulation of blood coagulation (GO:0030194) | 3.24779981 |
| 17 | positive regulation of hemostasis (GO:1900048) | 3.24779981 |
| 18 | axon ensheathment in central nervous system (GO:0032291) | 3.24491307 |
| 19 | central nervous system myelination (GO:0022010) | 3.24491307 |
| 20 | cell adhesion mediated by integrin (GO:0033627) | 3.24000006 |
| 21 | glycosphingolipid catabolic process (GO:0046479) | 3.21081344 |
| 22 | positive regulation of coagulation (GO:0050820) | 3.15468991 |
| 23 | negative regulation of complement activation (GO:0045916) | 3.13319376 |
| 24 | plasma lipoprotein particle assembly (GO:0034377) | 3.12097222 |
| 25 | termination of RNA polymerase I transcription (GO:0006363) | 3.10931586 |
| 26 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.10270013 |
| 27 | COPII vesicle coating (GO:0048208) | 3.09562230 |
| 28 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.08749231 |
| 29 | iron ion import (GO:0097286) | 3.07829516 |
| 30 | protein-lipid complex assembly (GO:0065005) | 3.03350143 |
| 31 | termination of RNA polymerase III transcription (GO:0006386) | 3.01994467 |
| 32 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.01994467 |
| 33 | rRNA modification (GO:0000154) | 3.00519681 |
| 34 | embryonic process involved in female pregnancy (GO:0060136) | 3.00202540 |
| 35 | plasma lipoprotein particle clearance (GO:0034381) | 2.99047458 |
| 36 | transcription from RNA polymerase I promoter (GO:0006360) | 2.97223884 |
| 37 | DNA deamination (GO:0045006) | 2.94962668 |
| 38 | maturation of SSU-rRNA (GO:0030490) | 2.93136731 |
| 39 | fibrinolysis (GO:0042730) | 2.92832434 |
| 40 | positive regulation of extracellular matrix organization (GO:1903055) | 2.91305524 |
| 41 | cholesterol efflux (GO:0033344) | 2.91012009 |
| 42 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.89215064 |
| 43 | glycolipid catabolic process (GO:0019377) | 2.88463363 |
| 44 | detection of other organism (GO:0098543) | 2.86590484 |
| 45 | nuclear pore complex assembly (GO:0051292) | 2.82750409 |
| 46 | 7-methylguanosine mRNA capping (GO:0006370) | 2.82217184 |
| 47 | GPI anchor biosynthetic process (GO:0006506) | 2.82201142 |
| 48 | regulation of cholesterol homeostasis (GO:2000188) | 2.80861045 |
| 49 | RNA capping (GO:0036260) | 2.78941065 |
| 50 | 7-methylguanosine RNA capping (GO:0009452) | 2.78941065 |
| 51 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.78875837 |
| 52 | ribosomal large subunit biogenesis (GO:0042273) | 2.78869981 |
| 53 | neutrophil activation involved in immune response (GO:0002283) | 2.76674095 |
| 54 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.75650917 |
| 55 | low-density lipoprotein particle remodeling (GO:0034374) | 2.70131613 |
| 56 | ribosome assembly (GO:0042255) | 2.70025889 |
| 57 | detection of bacterium (GO:0016045) | 2.68414067 |
| 58 | pinocytosis (GO:0006907) | 2.67972919 |
| 59 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.66697425 |
| 60 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.65703436 |
| 61 | protein carboxylation (GO:0018214) | 2.65703436 |
| 62 | regulation of cholesterol storage (GO:0010885) | 2.64507585 |
| 63 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.64331006 |
| 64 | Golgi transport vesicle coating (GO:0048200) | 2.63258293 |
| 65 | COPI coating of Golgi vesicle (GO:0048205) | 2.63258293 |
| 66 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.61454503 |
| 67 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.60157563 |
| 68 | acute-phase response (GO:0006953) | 2.60015540 |
| 69 | cellular extravasation (GO:0045123) | 2.59811831 |
| 70 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.59290381 |
| 71 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.58857027 |
| 72 | response to thyroid hormone (GO:0097066) | 2.58666690 |
| 73 | CENP-A containing nucleosome assembly (GO:0034080) | 2.56955600 |
| 74 | plasma lipoprotein particle organization (GO:0071827) | 2.56587150 |
| 75 | negative regulation of humoral immune response (GO:0002921) | 2.55236493 |
| 76 | protein-lipid complex subunit organization (GO:0071825) | 2.55180263 |
| 77 | negative regulation of interleukin-12 production (GO:0032695) | 2.52840708 |
| 78 | GPI anchor metabolic process (GO:0006505) | 2.52751789 |
| 79 | protein localization to endosome (GO:0036010) | 2.52730647 |
| 80 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.50367739 |
| 81 | viral transcription (GO:0019083) | 2.49970418 |
| 82 | regulation of apoptotic cell clearance (GO:2000425) | 2.49569814 |
| 83 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.49502661 |
| 84 | nucleotide transmembrane transport (GO:1901679) | 2.49403378 |
| 85 | cotranslational protein targeting to membrane (GO:0006613) | 2.48983453 |
| 86 | ribosomal small subunit assembly (GO:0000028) | 2.48615882 |
| 87 | protein-lipid complex remodeling (GO:0034368) | 2.48597456 |
| 88 | macromolecular complex remodeling (GO:0034367) | 2.48597456 |
| 89 | plasma lipoprotein particle remodeling (GO:0034369) | 2.48597456 |
| 90 | response to laminar fluid shear stress (GO:0034616) | 2.48516008 |
| 91 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.48289528 |
| 92 | rRNA methylation (GO:0031167) | 2.48179077 |
| 93 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.47368502 |
| 94 | regulation of activation of Janus kinase activity (GO:0010533) | 2.46234046 |
| 95 | translational termination (GO:0006415) | 2.46141961 |
| 96 | superoxide anion generation (GO:0042554) | 2.45366637 |
| 97 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.43998255 |
| 98 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.43726540 |
| 99 | ceramide catabolic process (GO:0046514) | 2.42976470 |
| 100 | protein targeting to ER (GO:0045047) | 2.42707147 |
| 101 | regulation of humoral immune response (GO:0002920) | 2.42404910 |
| 102 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.42258080 |
| 103 | lipoprotein metabolic process (GO:0042157) | 2.41920573 |
| 104 | cholesterol biosynthetic process (GO:0006695) | 2.40507753 |
| 105 | rRNA processing (GO:0006364) | 2.40474061 |
| 106 | phospholipid efflux (GO:0033700) | 2.40086978 |
| 107 | protein localization to endoplasmic reticulum (GO:0070972) | 2.39801151 |
| 108 | necroptotic process (GO:0070266) | 2.38592921 |
| 109 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.37921875 |
| 110 | response to interferon-beta (GO:0035456) | 2.37916937 |
| 111 | chromatin remodeling at centromere (GO:0031055) | 2.37258243 |
| 112 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.36866623 |
| 113 | urea metabolic process (GO:0019627) | 2.36836905 |
| 114 | nuclear pore organization (GO:0006999) | 2.34367042 |
| 115 | aldehyde catabolic process (GO:0046185) | 2.34225041 |
| 116 | L-serine metabolic process (GO:0006563) | 2.34051867 |
| 117 | phospholipid homeostasis (GO:0055091) | 2.34028926 |
| 118 | negative regulation of cholesterol transport (GO:0032375) | 2.33854129 |
| 119 | negative regulation of sterol transport (GO:0032372) | 2.33854129 |
| 120 | osteoclast differentiation (GO:0030316) | 2.33236800 |
| 121 | amino acid salvage (GO:0043102) | 2.32557761 |
| 122 | L-methionine salvage (GO:0071267) | 2.32557761 |
| 123 | L-methionine biosynthetic process (GO:0071265) | 2.32557761 |
| 124 | telomere maintenance via recombination (GO:0000722) | 2.32033240 |
| 125 | positive regulation of interferon-alpha production (GO:0032727) | 2.31915606 |
| 126 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.31403697 |
| 127 | regulation of interferon-alpha production (GO:0032647) | 2.30262422 |
| 128 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.30014141 |
| 129 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.29990857 |
| 130 | positive regulation of lipid storage (GO:0010884) | 2.29725125 |
| 131 | rRNA metabolic process (GO:0016072) | 2.29618568 |
| 132 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.28963649 |
| 133 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.28701265 |
| 134 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.28310969 |
| 135 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.28253007 |
| 136 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.28192990 |
| 137 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.27600132 |
| 138 | response to peptidoglycan (GO:0032494) | 2.27508443 |
| 139 | signal peptide processing (GO:0006465) | 2.27464774 |
| 140 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.27451277 |
| 141 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.27337233 |
| 142 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.26490581 |
| 143 | negative regulation of blood coagulation (GO:0030195) | 2.25948495 |
| 144 | negative regulation of hemostasis (GO:1900047) | 2.25948495 |
| 145 | complement activation, classical pathway (GO:0006958) | 2.25662482 |
| 146 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.25458516 |
| 147 | ribosome biogenesis (GO:0042254) | 2.24386900 |
| 148 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.23949604 |
| 149 | protein activation cascade (GO:0072376) | 2.23609157 |
| 150 | hypotonic response (GO:0006971) | 2.23598893 |
| 151 | regulation of response to interferon-gamma (GO:0060330) | 2.23576898 |
| 152 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.23496094 |
| 153 | regulation of vitamin metabolic process (GO:0030656) | 2.22599072 |
| 154 | complement activation (GO:0006956) | 2.22056171 |
| 155 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.22052081 |
| 156 | sphingosine metabolic process (GO:0006670) | 2.22023843 |
| 157 | regulation of cholesterol esterification (GO:0010872) | 2.22022184 |
| 158 | negative regulation of coagulation (GO:0050819) | 2.21901897 |
| 159 | urea cycle (GO:0000050) | 2.21405939 |
| 160 | membrane raft organization (GO:0031579) | 2.20815583 |
| 161 | response to muramyl dipeptide (GO:0032495) | 2.20427378 |
| 162 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.20240633 |
| 163 | pseudouridine synthesis (GO:0001522) | 2.19798256 |
| 164 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.19584191 |
| 165 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.19439221 |
| 166 | sphingoid metabolic process (GO:0046519) | 2.18885606 |
| 167 | negative regulation of lipid transport (GO:0032369) | 2.18561783 |
| 168 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.17850420 |
| 169 | regulation of antigen processing and presentation (GO:0002577) | 2.17542007 |
| 170 | fatty acid homeostasis (GO:0055089) | 2.17346802 |
| 171 | peptidyl-histidine modification (GO:0018202) | 2.16369964 |
| 172 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.15527493 |
| 173 | respiratory burst (GO:0045730) | 2.15289716 |
| 174 | kinetochore organization (GO:0051383) | 2.14435393 |
| 175 | NAD biosynthetic process (GO:0009435) | 2.13409181 |
| 176 | protein neddylation (GO:0045116) | 2.12521938 |
| 177 | sterol biosynthetic process (GO:0016126) | 2.12203890 |
| 178 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.11674714 |
| 179 | DNA-dependent DNA replication (GO:0006261) | 2.11137853 |
| 180 | positive regulation of interleukin-17 production (GO:0032740) | 2.10859840 |
| 181 | cellular response to interferon-beta (GO:0035458) | 2.10495501 |
| 182 | cellular component biogenesis (GO:0044085) | 2.10425182 |
| 183 | isoprenoid biosynthetic process (GO:0008299) | 2.09926922 |
| 184 | translation (GO:0006412) | 2.09916910 |
| 185 | cyclooxygenase pathway (GO:0019371) | 2.09555081 |
| 186 | regulation of metalloenzyme activity (GO:0048552) | 2.09519375 |
| 187 | negative regulation of mast cell activation (GO:0033004) | 2.08225492 |
| 188 | amyloid precursor protein metabolic process (GO:0042982) | 2.06448077 |
| 189 | neutrophil activation (GO:0042119) | 2.05810274 |
| 190 | detection of external biotic stimulus (GO:0098581) | 2.05044860 |
| 191 | serine family amino acid biosynthetic process (GO:0009070) | 2.03619789 |
| 192 | regulation of T cell migration (GO:2000404) | 2.03276692 |
| 193 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.02408146 |
| 194 | DNA replication initiation (GO:0006270) | 2.02247584 |
| 195 | kinetochore assembly (GO:0051382) | 2.01934341 |
| 196 | positive regulation of viral transcription (GO:0050434) | 2.00541103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.46233344 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.35727811 |
| 3 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.17320923 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.91672609 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.70651459 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.32891264 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.30748945 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.28593387 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.13580054 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.85395120 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.82951167 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.67986385 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.67930618 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.61620160 |
| 15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.56378225 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.44162714 |
| 17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.42959132 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.38228074 |
| 19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.32466434 |
| 20 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.32087400 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.29008162 |
| 22 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.28197256 |
| 23 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.23001121 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.22381437 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.18482898 |
| 26 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.16926083 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 2.15208251 |
| 28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.13602081 |
| 29 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.09131776 |
| 30 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.08123908 |
| 31 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 2.06448249 |
| 32 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.05100795 |
| 33 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.04804796 |
| 34 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.00508831 |
| 35 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.00292812 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.98527584 |
| 37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.94757111 |
| 38 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.89180689 |
| 39 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.88209038 |
| 40 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.81525663 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.77656791 |
| 42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.77388320 |
| 43 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77128333 |
| 44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.76589497 |
| 45 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.73516349 |
| 46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.69370304 |
| 47 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.68590792 |
| 48 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.67165268 |
| 49 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.65768589 |
| 50 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.65323558 |
| 51 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.64451152 |
| 52 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.64451152 |
| 53 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.64211887 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62081335 |
| 55 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.61618764 |
| 56 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.59412325 |
| 57 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.57389868 |
| 58 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.57309011 |
| 59 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.56878852 |
| 60 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.55440267 |
| 61 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.54509893 |
| 62 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.47879112 |
| 63 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.47574092 |
| 64 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.46648548 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.45307024 |
| 66 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.44415523 |
| 67 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.43952533 |
| 68 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43351155 |
| 69 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.43074046 |
| 70 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.42802386 |
| 71 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.40178956 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.39578787 |
| 73 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.38408045 |
| 74 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.38110528 |
| 75 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.38037280 |
| 76 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37557307 |
| 77 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.34614515 |
| 78 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.33293408 |
| 79 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33184388 |
| 80 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.32089100 |
| 81 | * MYB_26560356_Chip-Seq_TH2_Human | 1.31155291 |
| 82 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.31057547 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30517136 |
| 84 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.29342494 |
| 85 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.28054030 |
| 86 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23451581 |
| 87 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.22556744 |
| 88 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.21432886 |
| 89 | * MYB_26560356_Chip-Seq_TH1_Human | 1.21259806 |
| 90 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.20298266 |
| 91 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20198515 |
| 92 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.19919963 |
| 93 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.19356606 |
| 94 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.19020314 |
| 95 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.18863461 |
| 96 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18473820 |
| 97 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.18092349 |
| 98 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17012407 |
| 99 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16921279 |
| 100 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16776320 |
| 101 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16045528 |
| 102 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.15741155 |
| 103 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15471186 |
| 104 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.14358860 |
| 105 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.13846697 |
| 106 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13511050 |
| 107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13511050 |
| 108 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11631359 |
| 109 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.10830151 |
| 110 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10652093 |
| 111 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09977166 |
| 112 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.09685343 |
| 113 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.09351423 |
| 114 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.08049896 |
| 115 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07980965 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07552474 |
| 117 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07176872 |
| 118 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.06686046 |
| 119 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06073963 |
| 120 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06054473 |
| 121 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.04742978 |
| 122 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.04607893 |
| 123 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.04124469 |
| 124 | CJUN_26792858_Chip-Seq_BT549_Human | 1.03071659 |
| 125 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02954373 |
| 126 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02455564 |
| 127 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02320537 |
| 128 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00964601 |
| 129 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99305596 |
| 130 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.99251081 |
| 131 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.96807117 |
| 132 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95711236 |
| 133 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94317664 |
| 134 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.94316235 |
| 135 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.93409042 |
| 136 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.92319264 |
| 137 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.92048372 |
| 138 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.92030935 |
| 139 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91955410 |
| 140 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91097174 |
| 141 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90817852 |
| 142 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90807722 |
| 143 | GATA3_26560356_Chip-Seq_TH2_Human | 0.90758024 |
| 144 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90134415 |
| 145 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.89805663 |
| 146 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.89073868 |
| 147 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.88881063 |
| 148 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88420516 |
| 149 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.88395224 |
| 150 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87319584 |
| 151 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.87102398 |
| 152 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.86581100 |
| 153 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.86076824 |
| 154 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.85960499 |
| 155 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85678744 |
| 156 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85040674 |
| 157 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.84216161 |
| 158 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.80907034 |
| 159 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80166440 |
| 160 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.79901245 |
| 161 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.79680431 |
| 162 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.78755718 |
| 163 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76609690 |
| 164 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.76496822 |
| 165 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.76464343 |
| 166 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.76213179 |
| 167 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.76154273 |
| 168 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74759625 |
| 169 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.73882004 |
| 170 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73540192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 2.95039384 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.74224494 |
| 3 | MP0004381_abnormal_hair_follicle | 2.72901576 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 2.67915795 |
| 5 | MP0005451_abnormal_body_composition | 2.64724597 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.63926174 |
| 7 | MP0003136_yellow_coat_color | 2.50057119 |
| 8 | MP0003950_abnormal_plasma_membrane | 2.44774746 |
| 9 | MP0009785_altered_susceptibility_to | 2.39560610 |
| 10 | MP0008057_abnormal_DNA_replication | 2.30124304 |
| 11 | MP0003303_peritoneal_inflammation | 2.19370298 |
| 12 | MP0003186_abnormal_redox_activity | 2.16435998 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.12046945 |
| 14 | MP0005671_abnormal_response_to | 2.09682511 |
| 15 | MP0001853_heart_inflammation | 2.06092098 |
| 16 | MP0002796_impaired_skin_barrier | 2.04214562 |
| 17 | MP0002419_abnormal_innate_immunity | 2.01639217 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 2.01087368 |
| 19 | MP0006082_CNS_inflammation | 2.00794201 |
| 20 | MP0003436_decreased_susceptibility_to | 2.00760794 |
| 21 | MP0003718_maternal_effect | 1.98953993 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.98824509 |
| 23 | MP0009379_abnormal_foot_pigmentation | 1.98324346 |
| 24 | MP0005025_abnormal_response_to | 1.87689634 |
| 25 | MP0010352_gastrointestinal_tract_polyps | 1.87283601 |
| 26 | MP0002139_abnormal_hepatobiliary_system | 1.84540196 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.82373107 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.76959455 |
| 29 | MP0006054_spinal_hemorrhage | 1.72862772 |
| 30 | MP0002132_abnormal_respiratory_system | 1.71333751 |
| 31 | MP0003252_abnormal_bile_duct | 1.69817195 |
| 32 | MP0002723_abnormal_immune_serum | 1.67331005 |
| 33 | MP0001800_abnormal_humoral_immune | 1.66870276 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.62903355 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.61091664 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.57973474 |
| 37 | MP0001790_abnormal_immune_system | 1.55430536 |
| 38 | MP0005387_immune_system_phenotype | 1.55430536 |
| 39 | MP0000920_abnormal_myelination | 1.54138623 |
| 40 | MP0002009_preneoplasia | 1.54125385 |
| 41 | MP0009764_decreased_sensitivity_to | 1.51266238 |
| 42 | MP0003868_abnormal_feces_composition | 1.49343759 |
| 43 | MP0005408_hypopigmentation | 1.48917816 |
| 44 | MP0003566_abnormal_cell_adhesion | 1.48385016 |
| 45 | MP0003693_abnormal_embryo_hatching | 1.48359864 |
| 46 | MP0010234_abnormal_vibrissa_follicle | 1.46267315 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.43786234 |
| 48 | MP0003091_abnormal_cell_migration | 1.43540286 |
| 49 | MP0005501_abnormal_skin_physiology | 1.41796831 |
| 50 | MP0002420_abnormal_adaptive_immunity | 1.40022448 |
| 51 | MP0001819_abnormal_immune_cell | 1.39166978 |
| 52 | MP0000566_synostosis | 1.37392833 |
| 53 | MP0000609_abnormal_liver_physiology | 1.35989486 |
| 54 | MP0010329_abnormal_lipoprotein_level | 1.30349026 |
| 55 | MP0000604_amyloidosis | 1.29122514 |
| 56 | MP0004782_abnormal_surfactant_physiolog | 1.27784973 |
| 57 | MP0005085_abnormal_gallbladder_physiolo | 1.26641839 |
| 58 | MP0004947_skin_inflammation | 1.26268468 |
| 59 | MP0008438_abnormal_cutaneous_collagen | 1.24907160 |
| 60 | MP0001542_abnormal_bone_strength | 1.24567841 |
| 61 | MP0008469_abnormal_protein_level | 1.24540878 |
| 62 | MP0008058_abnormal_DNA_repair | 1.24443555 |
| 63 | MP0001915_intracranial_hemorrhage | 1.24252051 |
| 64 | MP0002405_respiratory_system_inflammati | 1.21666903 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.21425017 |
| 66 | MP0003690_abnormal_glial_cell | 1.21291436 |
| 67 | MP0005409_darkened_coat_color | 1.20064448 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 1.19950384 |
| 69 | MP0003941_abnormal_skin_development | 1.18306925 |
| 70 | MP0009840_abnormal_foam_cell | 1.17802637 |
| 71 | MP0001666_abnormal_nutrient_absorption | 1.16241079 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 1.15786505 |
| 73 | MP0005464_abnormal_platelet_physiology | 1.15574733 |
| 74 | MP0003183_abnormal_peptide_metabolism | 1.15277011 |
| 75 | MP0003075_altered_response_to | 1.15078930 |
| 76 | MP0000685_abnormal_immune_system | 1.14592457 |
| 77 | MP0001764_abnormal_homeostasis | 1.14069857 |
| 78 | MP0001216_abnormal_epidermal_layer | 1.13274957 |
| 79 | MP0001851_eye_inflammation | 1.12408708 |
| 80 | MP0008875_abnormal_xenobiotic_pharmacok | 1.12231300 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 1.10875699 |
| 82 | MP0010155_abnormal_intestine_physiology | 1.10015807 |
| 83 | MP0001661_extended_life_span | 1.09479070 |
| 84 | MP0005023_abnormal_wound_healing | 1.09477463 |
| 85 | MP0001533_abnormal_skeleton_physiology | 1.09406318 |
| 86 | MP0002998_abnormal_bone_remodeling | 1.09285836 |
| 87 | MP0001845_abnormal_inflammatory_respons | 1.09048688 |
| 88 | MP0002971_abnormal_brown_adipose | 1.08559599 |
| 89 | MP0003786_premature_aging | 1.05632147 |
| 90 | MP0003195_calcinosis | 1.05411748 |
| 91 | MP0000716_abnormal_immune_system | 1.04959980 |
| 92 | MP0009697_abnormal_copulation | 1.04497468 |
| 93 | MP0008260_abnormal_autophagy | 1.04349804 |
| 94 | MP0005058_abnormal_lysosome_morphology | 1.04248556 |
| 95 | MP0003705_abnormal_hypodermis_morpholog | 1.04016482 |
| 96 | MP0002060_abnormal_skin_morphology | 1.03678240 |
| 97 | MP0005670_abnormal_white_adipose | 1.03152274 |
| 98 | MP0003221_abnormal_cardiomyocyte_apopto | 1.02972431 |
| 99 | MP0000689_abnormal_spleen_morphology | 1.02930005 |
| 100 | MP0005076_abnormal_cell_differentiation | 1.02115053 |
| 101 | MP0004883_abnormal_blood_vessel | 1.01999165 |
| 102 | MP0002006_tumorigenesis | 1.01626843 |
| 103 | MP0002254_reproductive_system_inflammat | 1.01520605 |
| 104 | MP0003448_altered_tumor_morphology | 1.00414062 |
| 105 | MP0000383_abnormal_hair_follicle | 1.00102182 |
| 106 | MP0003763_abnormal_thymus_physiology | 0.99194961 |
| 107 | MP0009763_increased_sensitivity_to | 0.98957737 |
| 108 | MP0002396_abnormal_hematopoietic_system | 0.98047312 |
| 109 | MP0005360_urolithiasis | 0.97380258 |
| 110 | MP0008004_abnormal_stomach_pH | 0.96460298 |
| 111 | MP0000343_altered_response_to | 0.95922205 |
| 112 | MP0004272_abnormal_basement_membrane | 0.94255877 |
| 113 | MP0002118_abnormal_lipid_homeostasis | 0.93004306 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.91973459 |
| 115 | MP0002398_abnormal_bone_marrow | 0.91097435 |
| 116 | MP0004808_abnormal_hematopoietic_stem | 0.90969784 |
| 117 | MP0005166_decreased_susceptibility_to | 0.90889903 |
| 118 | MP0008007_abnormal_cellular_replicative | 0.90174815 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.89787364 |
| 120 | MP0000647_abnormal_sebaceous_gland | 0.89749750 |
| 121 | MP0002722_abnormal_immune_system | 0.89737837 |
| 122 | MP0005332_abnormal_amino_acid | 0.89222344 |
| 123 | MP0005395_other_phenotype | 0.88780299 |
| 124 | MP0005319_abnormal_enzyme/_coenzyme | 0.88222408 |
| 125 | MP0004147_increased_porphyrin_level | 0.87369202 |
| 126 | MP0004957_abnormal_blastocyst_morpholog | 0.86936616 |
| 127 | MP0005165_increased_susceptibility_to | 0.86836112 |
| 128 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86822370 |
| 129 | MP0000249_abnormal_blood_vessel | 0.86463523 |
| 130 | MP0005365_abnormal_bile_salt | 0.86371562 |
| 131 | MP0000598_abnormal_liver_morphology | 0.86015254 |
| 132 | MP0000372_irregular_coat_pigmentation | 0.85954370 |
| 133 | MP0002138_abnormal_hepatobiliary_system | 0.85442977 |
| 134 | MP0003045_fibrosis | 0.84969379 |
| 135 | MP0005275_abnormal_skin_tensile | 0.84594666 |
| 136 | MP0002429_abnormal_blood_cell | 0.84202804 |
| 137 | MP0001243_abnormal_dermal_layer | 0.83576302 |
| 138 | MP0009765_abnormal_xenobiotic_induced | 0.83567670 |
| 139 | MP0001188_hyperpigmentation | 0.83500562 |
| 140 | MP0005164_abnormal_response_to | 0.83472026 |
| 141 | MP0004233_abnormal_muscle_weight | 0.82448321 |
| 142 | MP0003828_pulmonary_edema | 0.81655135 |
| 143 | MP0000858_altered_metastatic_potential | 0.81135713 |
| 144 | MP0005647_abnormal_sex_gland | 0.79701660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 5.23632821 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.49461389 |
| 3 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.14469972 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.04244976 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.04244976 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.04244976 |
| 7 | Abnormality of the common coagulation pathway (HP:0010990) | 4.01106925 |
| 8 | Myocardial infarction (HP:0001658) | 3.93465385 |
| 9 | Complement deficiency (HP:0004431) | 3.80250604 |
| 10 | Parakeratosis (HP:0001036) | 3.77887442 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 3.53484206 |
| 12 | Abnormality of complement system (HP:0005339) | 3.38532061 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 3.36589000 |
| 14 | Hepatosplenomegaly (HP:0001433) | 3.24824485 |
| 15 | Duplicated collecting system (HP:0000081) | 3.24336072 |
| 16 | Erythroderma (HP:0001019) | 3.20329939 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.00809568 |
| 18 | Glomerulonephritis (HP:0000099) | 2.97983364 |
| 19 | Dysostosis multiplex (HP:0000943) | 2.92783209 |
| 20 | Xanthomatosis (HP:0000991) | 2.88006933 |
| 21 | 3-Methylglutaconic aciduria (HP:0003535) | 2.86500929 |
| 22 | Recurrent abscess formation (HP:0002722) | 2.82287173 |
| 23 | Abnormality of the renal collecting system (HP:0004742) | 2.78156915 |
| 24 | Mucopolysacchariduria (HP:0008155) | 2.75203024 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.75203024 |
| 26 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.74246191 |
| 27 | Abnormality of macrophages (HP:0004311) | 2.72497796 |
| 28 | Abnormality of secondary sexual hair (HP:0009888) | 2.70082937 |
| 29 | Abnormality of the axillary hair (HP:0100134) | 2.70082937 |
| 30 | Renal Fanconi syndrome (HP:0001994) | 2.66241290 |
| 31 | Prolonged partial thromboplastin time (HP:0003645) | 2.65416994 |
| 32 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.62883317 |
| 33 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.62883317 |
| 34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.62883317 |
| 35 | Recurrent bacterial skin infections (HP:0005406) | 2.62684035 |
| 36 | Gingival bleeding (HP:0000225) | 2.62160715 |
| 37 | Gangrene (HP:0100758) | 2.57190964 |
| 38 | Hypolipoproteinemia (HP:0010981) | 2.53976917 |
| 39 | Prolonged neonatal jaundice (HP:0006579) | 2.47879430 |
| 40 | Fatigue (HP:0012378) | 2.46272272 |
| 41 | Conjugated hyperbilirubinemia (HP:0002908) | 2.43673547 |
| 42 | Birth length less than 3rd percentile (HP:0003561) | 2.43266596 |
| 43 | Abnormality of the intrinsic pathway (HP:0010989) | 2.42507170 |
| 44 | Optic neuritis (HP:0100653) | 2.40392590 |
| 45 | Retrobulbar optic neuritis (HP:0100654) | 2.40392590 |
| 46 | Tetraparesis (HP:0002273) | 2.39697860 |
| 47 | Granulocytopenia (HP:0001913) | 2.38710838 |
| 48 | Breast hypoplasia (HP:0003187) | 2.38359053 |
| 49 | Fat malabsorption (HP:0002630) | 2.37412757 |
| 50 | Skin nodule (HP:0200036) | 2.36997456 |
| 51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.35964880 |
| 52 | Obstructive lung disease (HP:0006536) | 2.35964880 |
| 53 | Mitral stenosis (HP:0001718) | 2.33646961 |
| 54 | Joint hemorrhage (HP:0005261) | 2.31544748 |
| 55 | Stomatitis (HP:0010280) | 2.30985096 |
| 56 | Ectropion (HP:0000656) | 2.29716522 |
| 57 | Recurrent skin infections (HP:0001581) | 2.29663659 |
| 58 | Reticulocytopenia (HP:0001896) | 2.28435520 |
| 59 | Macrocytic anemia (HP:0001972) | 2.26365744 |
| 60 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.25368993 |
| 61 | Vertebral compression fractures (HP:0002953) | 2.24375330 |
| 62 | Prostate neoplasm (HP:0100787) | 2.23589097 |
| 63 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.23033037 |
| 64 | Hypercholesterolemia (HP:0003124) | 2.22899751 |
| 65 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.22369552 |
| 66 | Myositis (HP:0100614) | 2.21540470 |
| 67 | Increased hepatocellular lipid droplets (HP:0006565) | 2.19848761 |
| 68 | Loss of speech (HP:0002371) | 2.17605096 |
| 69 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.16931960 |
| 70 | Abnormal foot bone ossification (HP:0010675) | 2.16808236 |
| 71 | Subacute progressive viral hepatitis (HP:0006572) | 2.16751442 |
| 72 | Orchitis (HP:0100796) | 2.15392884 |
| 73 | Increased cerebral lipofuscin (HP:0011813) | 2.14564980 |
| 74 | Hemorrhage of the eye (HP:0011885) | 2.14471450 |
| 75 | Amyloidosis (HP:0011034) | 2.14256619 |
| 76 | Vascular calcification (HP:0004934) | 2.12932912 |
| 77 | Type I transferrin isoform profile (HP:0003642) | 2.12749823 |
| 78 | Chromsome breakage (HP:0040012) | 2.12707133 |
| 79 | Reduced antithrombin III activity (HP:0001976) | 2.10782988 |
| 80 | Vacuolated lymphocytes (HP:0001922) | 2.10774050 |
| 81 | Epidermoid cyst (HP:0200040) | 2.10042040 |
| 82 | Asymmetric septal hypertrophy (HP:0001670) | 2.07779948 |
| 83 | Lower limb hyperreflexia (HP:0002395) | 2.06821423 |
| 84 | IgG deficiency (HP:0004315) | 2.06241756 |
| 85 | Nephritis (HP:0000123) | 2.04807971 |
| 86 | Intrahepatic cholestasis (HP:0001406) | 2.04769210 |
| 87 | Renal cortical cysts (HP:0000803) | 2.04493093 |
| 88 | Purpura (HP:0000979) | 2.04028589 |
| 89 | Encephalitis (HP:0002383) | 2.03816416 |
| 90 | Abnormality of methionine metabolism (HP:0010901) | 2.02919490 |
| 91 | Sparse eyelashes (HP:0000653) | 2.02693249 |
| 92 | Polycythemia (HP:0001901) | 2.02517964 |
| 93 | Abnormality of the prostate (HP:0008775) | 2.02506054 |
| 94 | Arterial thrombosis (HP:0004420) | 2.02145759 |
| 95 | Cardiovascular calcification (HP:0011915) | 2.01213821 |
| 96 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.99804975 |
| 97 | Increased mean platelet volume (HP:0011877) | 1.99049044 |
| 98 | Steatorrhea (HP:0002570) | 1.98876982 |
| 99 | Lipid accumulation in hepatocytes (HP:0006561) | 1.98705701 |
| 100 | Congenital, generalized hypertrichosis (HP:0004540) | 1.98612079 |
| 101 | Thick nail (HP:0001805) | 1.98496513 |
| 102 | Eosinophilia (HP:0001880) | 1.98119131 |
| 103 | IgM deficiency (HP:0002850) | 1.97023444 |
| 104 | Disinhibition (HP:0000734) | 1.94675754 |
| 105 | Coarse hair (HP:0002208) | 1.93998622 |
| 106 | Keratoconjunctivitis sicca (HP:0001097) | 1.93671133 |
| 107 | Abnormal platelet volume (HP:0011876) | 1.92666156 |
| 108 | Abnormality of the lumbar spine (HP:0100712) | 1.91559140 |
| 109 | Interstitial pulmonary disease (HP:0006530) | 1.90898954 |
| 110 | Esophageal varix (HP:0002040) | 1.90149917 |
| 111 | Exertional dyspnea (HP:0002875) | 1.89870301 |
| 112 | Thrombophlebitis (HP:0004418) | 1.89797033 |
| 113 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.89182500 |
| 114 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.88985056 |
| 115 | Recurrent pneumonia (HP:0006532) | 1.87156513 |
| 116 | Hepatocellular carcinoma (HP:0001402) | 1.87033704 |
| 117 | Mediastinal lymphadenopathy (HP:0100721) | 1.86111342 |
| 118 | Epistaxis (HP:0000421) | 1.85856855 |
| 119 | Conical tooth (HP:0000698) | 1.85484969 |
| 120 | Autoimmune hemolytic anemia (HP:0001890) | 1.84029126 |
| 121 | Flat acetabular roof (HP:0003180) | 1.83011944 |
| 122 | Autoimmune thrombocytopenia (HP:0001973) | 1.82937347 |
| 123 | Increased CSF protein (HP:0002922) | 1.82876783 |
| 124 | Abnormal number of erythroid precursors (HP:0012131) | 1.82377670 |
| 125 | Sensory axonal neuropathy (HP:0003390) | 1.81839327 |
| 126 | Abnormal platelet function (HP:0011869) | 1.81802885 |
| 127 | Impaired platelet aggregation (HP:0003540) | 1.81802885 |
| 128 | Entropion (HP:0000621) | 1.81292139 |
| 129 | Petechiae (HP:0000967) | 1.80984781 |
| 130 | Hematochezia (HP:0002573) | 1.80824685 |
| 131 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.80361587 |
| 132 | Pancytopenia (HP:0001876) | 1.80282919 |
| 133 | Keratoconjunctivitis (HP:0001096) | 1.79946236 |
| 134 | Periodontitis (HP:0000704) | 1.79682045 |
| 135 | Hypoalphalipoproteinemia (HP:0003233) | 1.79018967 |
| 136 | Menorrhagia (HP:0000132) | 1.77780500 |
| 137 | Recurrent viral infections (HP:0004429) | 1.77174343 |
| 138 | Meningitis (HP:0001287) | 1.76968790 |
| 139 | Stenosis of the external auditory canal (HP:0000402) | 1.76448218 |
| 140 | Glomerulopathy (HP:0100820) | 1.75895733 |
| 141 | T lymphocytopenia (HP:0005403) | 1.75495588 |
| 142 | Pulmonary embolism (HP:0002204) | 1.75482996 |
| 143 | Pallor (HP:0000980) | 1.75467302 |
| 144 | Pruritus (HP:0000989) | 1.75363432 |
| 145 | Pulmonary infiltrates (HP:0002113) | 1.75154568 |
| 146 | Papillary thyroid carcinoma (HP:0002895) | 1.75084245 |
| 147 | Increased serum ferritin (HP:0003281) | 1.74655225 |
| 148 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.74643511 |
| 149 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.74559497 |
| 150 | Progressive external ophthalmoplegia (HP:0000590) | 1.74098901 |
| 151 | Stomach cancer (HP:0012126) | 1.74039388 |
| 152 | Abnormality of renal resorption (HP:0011038) | 1.73094324 |
| 153 | Syringomyelia (HP:0003396) | 1.72952193 |
| 154 | Spinal cord lesions (HP:0100561) | 1.72952193 |
| 155 | Abnormal spermatogenesis (HP:0008669) | 1.72729254 |
| 156 | Abnormality of T cell number (HP:0011839) | 1.71464642 |
| 157 | Erythema (HP:0010783) | 1.71367197 |
| 158 | Asymmetry of the thorax (HP:0001555) | 1.70656709 |
| 159 | Leukocytosis (HP:0001974) | 1.70482717 |
| 160 | Abnormality of eosinophils (HP:0001879) | 1.70072030 |
| 161 | Acute hepatic failure (HP:0006554) | 1.69706031 |
| 162 | Dry hair (HP:0011359) | 1.69621077 |
| 163 | Thickened calvaria (HP:0002684) | 1.69180068 |
| 164 | Upper motor neuron abnormality (HP:0002127) | 1.68587711 |
| 165 | Rough bone trabeculation (HP:0100670) | 1.67173249 |
| 166 | Vasculitis (HP:0002633) | 1.65985957 |
| 167 | Poor head control (HP:0002421) | 1.65979709 |
| 168 | Patchy hypopigmentation of hair (HP:0011365) | 1.65691966 |
| 169 | Autoamputation (HP:0001218) | 1.64351147 |
| 170 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.64318186 |
| 171 | Azoospermia (HP:0000027) | 1.63617419 |
| 172 | Ureteral duplication (HP:0000073) | 1.63523824 |
| 173 | Recurrent cutaneous fungal infections (HP:0011370) | 1.63482590 |
| 174 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.63482590 |
| 175 | Asplenia (HP:0001746) | 1.63149036 |
| 176 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.63078362 |
| 177 | Osteolytic defects of the hand bones (HP:0009699) | 1.63078362 |
| 178 | Hyperlipoproteinemia (HP:0010980) | 1.63069350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.01147919 |
| 2 | PBK | 3.22625185 |
| 3 | STK16 | 2.72232102 |
| 4 | IRAK4 | 2.60846395 |
| 5 | NME2 | 2.50868220 |
| 6 | MST4 | 2.47204803 |
| 7 | EIF2AK1 | 2.29414085 |
| 8 | TXK | 2.22037540 |
| 9 | PLK4 | 2.18910413 |
| 10 | EIF2AK3 | 2.13551617 |
| 11 | SRPK1 | 2.09917317 |
| 12 | SCYL2 | 2.03171179 |
| 13 | JAK1 | 1.98309401 |
| 14 | ERN1 | 1.98274133 |
| 15 | BUB1 | 1.94536760 |
| 16 | MAP3K14 | 1.94463018 |
| 17 | FGFR4 | 1.89919960 |
| 18 | ZAK | 1.88255555 |
| 19 | CAMKK2 | 1.86216932 |
| 20 | CDK6 | 1.85495780 |
| 21 | FGFR3 | 1.85445815 |
| 22 | NEK6 | 1.76875890 |
| 23 | BLK | 1.75004481 |
| 24 | PRPF4B | 1.74881945 |
| 25 | MAP3K2 | 1.70512173 |
| 26 | WEE1 | 1.70102715 |
| 27 | EIF2AK2 | 1.66753546 |
| 28 | MAP2K3 | 1.65596510 |
| 29 | LATS1 | 1.64409409 |
| 30 | VRK1 | 1.63852644 |
| 31 | MKNK2 | 1.55922922 |
| 32 | BRSK2 | 1.53406943 |
| 33 | IRAK1 | 1.52652301 |
| 34 | MAP3K13 | 1.51058582 |
| 35 | IRAK2 | 1.47200482 |
| 36 | CDK12 | 1.47138898 |
| 37 | STK39 | 1.44424904 |
| 38 | MKNK1 | 1.42485387 |
| 39 | TEC | 1.42207971 |
| 40 | KSR2 | 1.38135976 |
| 41 | MAP3K3 | 1.37877813 |
| 42 | TLK1 | 1.37238558 |
| 43 | CLK1 | 1.33821807 |
| 44 | MST1R | 1.32503703 |
| 45 | PDGFRA | 1.32033384 |
| 46 | IKBKB | 1.31323886 |
| 47 | ERBB3 | 1.26584810 |
| 48 | NEK1 | 1.25868715 |
| 49 | MAP4K1 | 1.24651510 |
| 50 | AKT3 | 1.21050662 |
| 51 | BMPR1B | 1.19883805 |
| 52 | PIM2 | 1.19132585 |
| 53 | ABL2 | 1.18456898 |
| 54 | STK10 | 1.16483330 |
| 55 | NLK | 1.13758785 |
| 56 | NEK9 | 1.13002750 |
| 57 | KIT | 1.11109186 |
| 58 | TYK2 | 1.09700774 |
| 59 | TTN | 1.08482963 |
| 60 | STK24 | 1.08427139 |
| 61 | BRD4 | 1.08193475 |
| 62 | KDR | 1.03824866 |
| 63 | GRK7 | 1.03695046 |
| 64 | PDK2 | 0.99662392 |
| 65 | RIPK4 | 0.97869411 |
| 66 | ADRBK2 | 0.96016594 |
| 67 | GRK1 | 0.95589003 |
| 68 | NUAK1 | 0.95011327 |
| 69 | OXSR1 | 0.93918222 |
| 70 | PKN1 | 0.92044682 |
| 71 | TESK2 | 0.91962913 |
| 72 | STK4 | 0.91229765 |
| 73 | LATS2 | 0.90355718 |
| 74 | JAK3 | 0.89940647 |
| 75 | MAPK11 | 0.89456166 |
| 76 | MAPKAPK5 | 0.88236330 |
| 77 | PRKAA2 | 0.87743985 |
| 78 | ITK | 0.87579877 |
| 79 | JAK2 | 0.87297514 |
| 80 | CAMK1D | 0.86292608 |
| 81 | BCKDK | 0.86243135 |
| 82 | RPS6KA5 | 0.86171228 |
| 83 | DDR2 | 0.86072516 |
| 84 | MAP3K1 | 0.85751717 |
| 85 | RIPK1 | 0.84192305 |
| 86 | PDGFRB | 0.82234158 |
| 87 | MOS | 0.80620513 |
| 88 | LYN | 0.80226301 |
| 89 | BMPR2 | 0.79883049 |
| 90 | IKBKE | 0.79776880 |
| 91 | DYRK3 | 0.79585905 |
| 92 | PIK3CG | 0.79335439 |
| 93 | KSR1 | 0.78204726 |
| 94 | BTK | 0.78036624 |
| 95 | SIK3 | 0.75875820 |
| 96 | MELK | 0.75093954 |
| 97 | LCK | 0.73837542 |
| 98 | ACVR1B | 0.73356444 |
| 99 | MAP3K12 | 0.73234637 |
| 100 | YES1 | 0.72772621 |
| 101 | EPHB1 | 0.71170102 |
| 102 | PLK3 | 0.71109500 |
| 103 | PAK4 | 0.70524801 |
| 104 | TRPM7 | 0.69269887 |
| 105 | CSF1R | 0.68623295 |
| 106 | TTK | 0.68552602 |
| 107 | PDPK1 | 0.68280060 |
| 108 | FGR | 0.67024056 |
| 109 | PIM1 | 0.66453789 |
| 110 | MAP3K5 | 0.65994360 |
| 111 | TNIK | 0.65961867 |
| 112 | STK3 | 0.65596203 |
| 113 | ICK | 0.65193319 |
| 114 | CSK | 0.63782633 |
| 115 | TGFBR2 | 0.62039515 |
| 116 | TAOK2 | 0.61462117 |
| 117 | SYK | 0.60488601 |
| 118 | MARK3 | 0.59696356 |
| 119 | ERBB4 | 0.59127261 |
| 120 | RAF1 | 0.57692019 |
| 121 | MATK | 0.57495365 |
| 122 | EPHA3 | 0.55037872 |
| 123 | TSSK6 | 0.54537388 |
| 124 | MET | 0.53738091 |
| 125 | EEF2K | 0.52945308 |
| 126 | CSNK1G3 | 0.52357884 |
| 127 | PDK1 | 0.52351056 |
| 128 | DYRK2 | 0.52175781 |
| 129 | SGK3 | 0.50896156 |
| 130 | CDK7 | 0.50775005 |
| 131 | MAPK15 | 0.50324464 |
| 132 | MAP3K6 | 0.49989664 |
| 133 | PLK1 | 0.48831444 |
| 134 | STK38L | 0.48456681 |
| 135 | MAP3K8 | 0.48253414 |
| 136 | CSNK2A1 | 0.47343026 |
| 137 | RPS6KA4 | 0.47208808 |
| 138 | RET | 0.47163655 |
| 139 | PRKCQ | 0.46526986 |
| 140 | BCR | 0.46491787 |
| 141 | PINK1 | 0.46238822 |
| 142 | CDC7 | 0.46062936 |
| 143 | CSNK1G1 | 0.45880086 |
| 144 | TBK1 | 0.45800297 |
| 145 | TAOK3 | 0.45482022 |
| 146 | ABL1 | 0.44340978 |
| 147 | WNK1 | 0.43661161 |
| 148 | CAMK1G | 0.43329346 |
| 149 | HCK | 0.43183169 |
| 150 | AURKB | 0.43077076 |
| 151 | CSNK1A1L | 0.42856201 |
| 152 | EPHA2 | 0.42822855 |
| 153 | ZAP70 | 0.42596662 |
| 154 | CDK4 | 0.42252205 |
| 155 | CDC42BPA | 0.41215534 |
| 156 | FER | 0.41167472 |
| 157 | AURKA | 0.41061792 |
| 158 | IGF1R | 0.40624264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 2.91168032 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 2.89165281 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.44455870 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.30101098 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.29367400 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.20432282 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.18213394 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.17202706 |
| 9 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.07952078 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 2.00804478 |
| 11 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.89287083 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.86130135 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.84545855 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 1.70996889 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.70729018 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.64757149 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 1.60026970 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.59975465 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59255550 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.53925490 |
| 21 | Basal transcription factors_Homo sapiens_hsa03022 | 1.52295253 |
| 22 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.51385760 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50012948 |
| 24 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.49769754 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.49637325 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.49422528 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.49239910 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.48651602 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44261545 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.42239082 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.40442737 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.39354139 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.37217294 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.31629369 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.29782953 |
| 36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.28231623 |
| 37 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.28111670 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.27967778 |
| 39 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.27902185 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26213198 |
| 41 | Spliceosome_Homo sapiens_hsa03040 | 1.25494770 |
| 42 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.24193907 |
| 43 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.24016183 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.22362626 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.22091555 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.21179546 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 1.20021825 |
| 48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.18417882 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 1.18393264 |
| 50 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.14389524 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 1.14291319 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 1.13710622 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.11747163 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10927865 |
| 55 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.10873313 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.09382332 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.09322443 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.09233360 |
| 59 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09084927 |
| 60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08871119 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08707515 |
| 62 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.08440684 |
| 63 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08319813 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.07692289 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.07630078 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.06388396 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.00902556 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98803020 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.96876207 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95781746 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94909813 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.94660483 |
| 73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.94265393 |
| 74 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94253048 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.93173680 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.93039340 |
| 77 | Asthma_Homo sapiens_hsa05310 | 0.92854339 |
| 78 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.91934007 |
| 79 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.91901375 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90293730 |
| 81 | Hepatitis B_Homo sapiens_hsa05161 | 0.89704051 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.89161696 |
| 83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88633573 |
| 84 | Purine metabolism_Homo sapiens_hsa00230 | 0.85960517 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85755708 |
| 86 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.85398039 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84939013 |
| 88 | Base excision repair_Homo sapiens_hsa03410 | 0.84674376 |
| 89 | RNA degradation_Homo sapiens_hsa03018 | 0.83518848 |
| 90 | Parkinsons disease_Homo sapiens_hsa05012 | 0.83272313 |
| 91 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.83222963 |
| 92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81852601 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81367664 |
| 94 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79803715 |
| 95 | Measles_Homo sapiens_hsa05162 | 0.78013727 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.77955748 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76756585 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75917029 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.75458380 |
| 100 | Salmonella infection_Homo sapiens_hsa05132 | 0.75457093 |
| 101 | Shigellosis_Homo sapiens_hsa05131 | 0.75345297 |
| 102 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.74762815 |
| 103 | Leishmaniasis_Homo sapiens_hsa05140 | 0.74214445 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73841414 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72630101 |
| 106 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72204149 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71764021 |
| 108 | RNA transport_Homo sapiens_hsa03013 | 0.70344062 |
| 109 | Bladder cancer_Homo sapiens_hsa05219 | 0.69881338 |
| 110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.69642434 |
| 111 | Legionellosis_Homo sapiens_hsa05134 | 0.69405977 |
| 112 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68866738 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.68757897 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68556587 |
| 115 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.67805229 |
| 116 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66958748 |
| 117 | Apoptosis_Homo sapiens_hsa04210 | 0.66916099 |
| 118 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66616384 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66411202 |
| 120 | Huntingtons disease_Homo sapiens_hsa05016 | 0.65469533 |
| 121 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63311468 |
| 122 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62101453 |
| 123 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62077386 |
| 124 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.61965376 |
| 125 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61072248 |
| 126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60417290 |
| 127 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57993413 |
| 128 | Phagosome_Homo sapiens_hsa04145 | 0.56957889 |
| 129 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.56708017 |
| 130 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55987789 |
| 131 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55702849 |
| 132 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.55111004 |
| 133 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54386975 |
| 134 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53396826 |
| 135 | Mineral absorption_Homo sapiens_hsa04978 | 0.53381166 |
| 136 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53227625 |
| 137 | Other glycan degradation_Homo sapiens_hsa00511 | 0.52900212 |
| 138 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52161124 |
| 139 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51880659 |
| 140 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.51642506 |
| 141 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50448927 |
| 142 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50429709 |
| 143 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49966665 |
| 144 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49353343 |
| 145 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49189809 |
| 146 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49058290 |
| 147 | Alzheimers disease_Homo sapiens_hsa05010 | 0.48764138 |
| 148 | Lysosome_Homo sapiens_hsa04142 | 0.48560970 |
| 149 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.48474428 |
| 150 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.47963114 |
| 151 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47801637 |
| 152 | Platelet activation_Homo sapiens_hsa04611 | 0.47773209 |
| 153 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46652232 |
| 154 | Bile secretion_Homo sapiens_hsa04976 | 0.46568260 |
| 155 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45349693 |
| 156 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44509950 |

